Intco Medical Technology Co., Ltd. (SHE:300677)
49.42
+2.47 (5.26%)
Nov 17, 2026, 3:04 PM CST
Intco Medical Technology Revenue
Intco Medical Technology had revenue of 3.71B CNY in the quarter ending September 30, 2026, with 47.72% growth. This brings the company's total for the last twelve months to 13.12B, up 33.20% year-over-year. In the year 2025, Intco Medical Technology had annual revenue of 9.93B with 4.23% growth. That makes Intco Medical Technology the 5,037th largest company in the world by revenue and 656th in China.
Revenue (ttm)
13.12B
Revenue Growth
+33.20%
P/S Ratio
2.44
Revenue / Employee
1.01M
Employees
12,941
Market Cap
32.01B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Intco Medical Technology breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.93B | 402.50M | 4.23% |
| Dec 31, 2024 | 9.52B | 2.60B | 37.65% |
| Dec 31, 2023 | 6.92B | 304.91M | 4.61% |
| Jan 1, 2023 | 6.61B | -9.63B | -59.27% |
| Jan 1, 2022 | 16.24B | 2.40B | 17.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Winner Medical | 11.25B |
| Tofflon Science and Technology Group | 5.15B |
| Zhende Medical | 4.65B |
| Gan & Lee Pharmaceuticals. | 4.37B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.32B |
| iRay Group | 3.20B |
| Imeik Technology Development | 2.33B |
| Autek China | 1.82B |